Litigation Details for Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)
✉ Email this page to a colleague
Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-12-02 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 28:2201 Declaratory Judgment | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 8,163,723; 8,168,620; 9,259,428 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Meda Pharmaceuticals Inc. v. Apotex Inc.
Biologic Drugs cited in Meda Pharmaceuticals Inc. v. Apotex Inc.
Details for Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-04-07 | 102 | Initial Invalidity Contentions for U.S. Patent No. 9,259,428 Pursuant to the Courts Default Standard … 2 December 2014 1:14-cv-01453-LPS Patent None District Court, D. Delaware | External link to document | |
2016-05-12 | 114 | .S. Patent Nos. 8,163,723 (the "' 723 patent"), 8,168,620 (the "'620 patent"…), and 9,259,428 (the '"428 patent"). The patents are directed to a single-dosage formulation…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …28 of the ' 723 patent and claims 16, 17, and 24 of the of the ' 620 patent. 3 | External link to document | |
2016-12-12 | 148 | Prejudice of all Claims Concerning U.S. Patent No. 8,163,723 by Cipla Ltd., Meda Pharmaceuticals Inc.… 2 December 2014 1:14-cv-01453-LPS Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |